News
TipRanks on MSN14h
Kalaris Therapeutics initiated with an Outperform at William BlairWilliam Blair initiated coverage of Kalaris Therapeutics (KLRS) with an Outperform rating and $21 fair value estimate. Kalaris is a clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback